These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14624145)

  • 21. Thiazolidinediones: a new class of drugs for the therapy of ischemia-reperfusion injury.
    Naito Y; Yoshikawa T
    Drugs Today (Barc); 2004 May; 40(5):423-30. PubMed ID: 15319797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
    Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
    Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
    Pickavance LC; Brand CL; Wassermann K; Wilding JP
    Br J Pharmacol; 2005 Feb; 144(3):308-16. PubMed ID: 15655531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
    Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
    Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.
    Camacho IE; Serneels L; Spittaels K; Merchiers P; Dominguez D; De Strooper B
    J Neurosci; 2004 Dec; 24(48):10908-17. PubMed ID: 15574741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.
    Davies GF; McFie PJ; Khandelwal RL; Roesler WJ
    J Pharmacol Exp Ther; 2002 Jan; 300(1):72-7. PubMed ID: 11752099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation.
    Hong G; Davis B; Khatoon N; Baker SF; Brown J
    Biochem Biophys Res Commun; 2003 Apr; 303(3):782-7. PubMed ID: 12670479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
    Shimizu K; Shiratori K; Hayashi N; Kobayashi M; Fujiwara T; Horikoshi H
    Pancreas; 2002 Mar; 24(2):184-90. PubMed ID: 11854624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.
    Suzuki A; Yasuno T; Kojo H; Hirosumi J; Mutoh S; Notsu Y
    Jpn J Pharmacol; 2000 Oct; 84(2):113-23. PubMed ID: 11128033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
    Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma.
    Chana RS; Brunskill NJ
    Am J Nephrol; 2006; 26(1):67-74. PubMed ID: 16508249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
    Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages.
    Iida KT; Kawakami Y; Suzuki H; Sone H; Shimano H; Toyoshima H; Okuda Y; Yamada N
    FEBS Lett; 2002 Jun; 520(1-3):177-81. PubMed ID: 12044893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
    Knight B; Yeap BB; Yeoh GC; Olynyk JK
    Carcinogenesis; 2005 Oct; 26(10):1782-92. PubMed ID: 15917308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
    Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.